Table 4.
Comparison of incidence rates of adverse events between the two groups during treatment and follow-up [n (%)]
| Adverse event | Group A (n=180) | Group B (n=120) | X2 | P | |
|---|---|---|---|---|---|
| Complications after PCI | 0 (0.00) | 8 (6.67) | 12.329 | < 0.001 | |
| MACE during hospital stay | Myocardial reinfarction | 0 (0.00) | 3 (2.50) | ||
| Cardiogenic death | 0 (0.00) | 1 (0.83) | |||
| Total | 0 (0.00) | 4 (3.33) | 6.081 | 0.014 | |
| MACE 2 years after surgery | Myocardial reinfarction | ||||
| Revascularization | 7 (5.83) | ||||
| Cardiogenic death | 3 (2.50) | ||||
| Total | 16 (13.33) | 21.991 | < 0.001 | ||